SaferSkin™

SaferSkin Case Study Corner

SaferSkin™ three well-adopted defined approaches to perform an integrated analysis of the OECD-approved in vitro tests

Integrated Approaches to solving Skin Safety Assessment problems

Skin safety is one of the most important goals of the consumer products industry.

Improved skin sensitisation safety assessment

Swiss firm TEMAS believes that progress only happens when people work together in networks, crossing the boundaries of specialist fields.

SaferSkin™ Launched at SOT

SaferSkin™ is a cloud-based software application and collaboration platform, supporting Integrated Testing Strategies to predict the skin sensitization potential of chemical entities.

SaferSkin™ for animal-free tests

SaferSkin™ combines three of the top methods for ITS: the Bayesian Network approach, Multiple Regression Analysis and ‘2 out of 3‘ Weight of Evidence.

A more powerful way to test skin sensitisation

More accurate, reproducible risk assessment to determine whether a substance is a skin sensitiser

About Edelweiss Connect

Edelweiss Connect has developed computer software that helps combine data from many different sources and formats into a useable form for evaluation and re-use. In addition, we have developed other software programs that can use the collected data and data from in vitro tests to predict the safety of chemical compounds in the human body.

Latest Tweets

Edelweiss Connect (2 weeks ago)
RT @barryhardy: Cosmetics Assessment is an area with a strong need for use of non-animal testing methods and continuing innovation in testi…
Edelweiss Connect (2 weeks ago)
RT @barryhardy: Discussion of COVID-19 work using modelling and informatics 19 CEST, Tuesday 22 September, OpenTox 2020 virtual conference…
Edelweiss Connect (2 weeks ago)
Join us for the 2020 OpenTox Virtual Conference Sep 21-25 The OpenTox 2020 Conference activity will be supported b… https://t.co/azV6JH5sJI
Edelweiss Connect (2 months ago)
#SaferWorldbyDesign Use of alternative skin models for animal-free safety and efficacy testing in dermatology resea… https://t.co/I9wkhBRjZm
Edelweiss Connect (2 months ago)
RT @barryhardy: The activities of drug inactive ingredients on biological targets This #OpenTox Webinar (Thursday 8 August) will include a…

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA